Invention Grant
US08575174B2 Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
有权
氘代1-哌嗪基-3-苯基 - 茚烷用于治疗精神分裂症
- Patent Title: Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
- Patent Title (中): 氘代1-哌嗪基-3-苯基 - 茚烷用于治疗精神分裂症
-
Application No.: US13527364Application Date: 2012-06-19
-
Publication No.: US08575174B2Publication Date: 2013-11-05
- Inventor: Morten Jorgensen , Peter Hongaard Andersen , Klaus Gjervig Jensen , Mette Graulund Hvenegaard , Lassina Badolo , Mikkel Fog Jacobsen
- Applicant: Morten Jorgensen , Peter Hongaard Andersen , Klaus Gjervig Jensen , Mette Graulund Hvenegaard , Lassina Badolo , Mikkel Fog Jacobsen
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: Wilmer Cutler Pickering Hale and Dorr LLP
- Main IPC: A61K31/495
- IPC: A61K31/495
Abstract:
The present invention relates to deuterated 1-piperazino-3-phenyl-indanes and salts thereof with activity at dopamine receptors D1 and D2 as well as the 5HT2 receptors in the central nervous system, to medicaments comprising such compounds as active ingredients, to the use of such compounds in the treatment of diseases in the central nervous system, and to methods of treatment comprising administration of such compounds.
Public/Granted literature
- US20120322811A1 DEUTERATED 1-PIPERAZINO-3-PHENYL-INDANES FOR TREATMENT OF SCHIZOPHRENIA Public/Granted day:2012-12-20
Information query
